Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Hilton Hotels Corporation Common Stock (HLT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Hilton Hotels Corporation Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $36.9 (market cap $4.59B), while Hilton Hotels Corporation Common Stock trades at $326.56 (market cap $72.76B). The key difference: Hilton Hotels Corporation Common Stock is far larger — about 15.9× Definium Therapeutics Inc. Common Shares's market cap, and Hilton Hotels Corporation Common Stock pays a 0.19% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Hilton Hotels Corporation Common Stock for 138 Days on average.
| DFTX | HLT | |
|---|---|---|
Market Cap | $4.59B | $72.76B |
Volume | 2,103,937 | 1,148,634 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.45 | $350.22 |
52-Week Low | $10.68 | $256.96 |
Typical Hold Time | 0 Days | 138 Days |
Enterprise Value | $3.55B | $85.78B |
Dividend Yield | — | 0.19% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Hilton Worldwide (HLT) trades at $323.29, up 0.87% today, with a bullish technical signal and strong earnings momentum after beating estimates for three consecutive quarters. Revenue grew to $12.04B in 2025, with a net income margin of 12.69%, though valuation ratios like a P/E of 47.47 appear elevated. Recent news highlights institutional buying and the upcoming Q3 2026 earnings report on October 27, 2026.
The outlook is positive with analyst consensus at Buy (57% of 49 analysts) and a $348.11 price target, but risks include high debt levels (debt-to-asset ratio of 73.88% in 2025) and reliance on travel demand. Upside hinges on continued revenue growth and margin stability amid economic uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Hilton Hotels Corporation Common Stock
Hilton Worldwide Holdings operates 1,074,791 rooms across its 18 brands addressing the midscale through luxury segments as of Dec. 31, 2021. Hampton and Hilton are the two largest brands by total room count at 28% and 21%, respectively, as of Dec. 31, 2021. Recent brands launched over the last few years include Home2, Curio, Canopy, Tru, and Tempo. Managed and franchised represent the vast majority of adjusted EBITDA, predominantly from the Americas regions.
Read more on HLT →
